Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Retired Engineer, consults on unusual and/or difficult technical and marketing problems.
Author of the Amazon E-Book "Rich Geeks and Gifts from Greeks"
Intel and Tektronix
DARPA Principal Investigator
Management experience including six startups
High level management training and experience
Long term investor, infrequent trading
Dr. Robert N. Castellano, president of The Information Network (http://www.theinformationnet.com/), received a Ph.D. degree in solid state chemistry from Oxford University (England). He has had ten years experience in the field of wafer fabrication at AT&T Bell Laboratories and Stanford University. He has authored numerous reports for other publishing companies before founding The Information Network in 1985. He has been editor of the peer-reviewed Journal of Active and Passive Electronic Devices since 1985. He writes a monthly column in “Vacuum Technology & Coating” magazine and “Wafer & Device Packaging Interconnect” magazine. He is author of the book "Technology Trends in VLSI Manufacturing" published by Gordon and Breach. He is also a Senior Contributor to TheStreet.com. His book "Solar Panel Processing" was published in 2009 by Old City Publishing. His latest book, "Alternative Energy Technology" was published in 2012. Also in the solar area, he is CEO of SolarPA, which uses a proprietary nanomaterial to coat solar cells, increasing the efficiency by up to 10%. He had been on the Advisory Board of Principal Solar. He recently published a fictional novel Blessed, available on Amazon and other sites.
Dan Rayburn is Executive Vice President for StreamingMedia.com (http://www.streamingmedia.com/) and is recognized by many as the voice for the streaming and online video industry. He is also a Principal Analyst with Frost & Sullivan, working in their Digital Media group. He is a sought after speaker, writer, publisher, and consultant, and his work has been featured in print and online by nearly every major media outlet over the past 14 years. He co-founded one of the industry's first streaming media webcasting production companies successfully acquired by Digital Island for $70M. He has his own line of books for Focal Press entitled "The Dan Rayburn Hands On Guide" Series, with eight titles available in print. Regularly consulted by the media, he has been featured in hundreds of print and online articles and is a sought after expert in patent cases involving IP-based video. He is a regular analyst to the investment community via the Gerson Lehrman Group and his Business of Video (http://www.BusinessOfVideo.com/) blog is one of the most widely read sites for analysts, venture capitalists, and financial money managers who cover companies in the online video sector.
Visit Dan Rayburn (http://blog.streamingmedia.com/)'s site.
I have retired from a 35 years career in the semiconductor industry. I now have the time to do the deep research necessary for successful investing.
I freely provide investment information for friends and family.
I am a member of MENSA, which means precisely nothing except I wake up in the middle of the night doing pointless math problems in my head:)
Dana Blankenhorn http://www.danablankenhorn.com has been a business journalist since 1978, and a futurist all his life.He warned about the coming Houston oil collapse in 1979. He began making a living on the Internet in 1985. He launched the first e-commerce daily for CMP in 1994, warned of the coming dot-bomb at a-clue.com in 1997 and began covering the Internet of Things in 2003.Along the way he's written for a host of newspapers, magazines, news services and Web sites. Most recently he was at TheStreet.com, covering technology and investments. He still has time for freelance assignments. He lives in Atlanta.
Ashraf Eassa is a technology specialist with The Motley Fool. He writes mostly about technology stocks, but is especially interested in anything related to chips -- the semiconductor kind, that is.
The founding members of Chimera Research Group have over 50 years of combined experience in the biotech and pharmaceutical sector. Their experience includes work at Investment Banks, Hedge Funds, Pharmaceutical Companies, top-tier Universities, and the U.S. Food and Drug Administration (FDA). Their published work includes freelance and editorial contributions both print and on-line, clinical and medical research, books and tutorials, as well as contributions to on-line social media. Through these and other activities they were able to collaborate and connect amongst themselves to establish this cadre of like-minded biotech/pharma trading and investing aficionados.
The Team includes:
Chief Scientific Analyst - Jason Chew
Chief Research Analyst - Patrick Crutcher
Chief Medical Analyst - Dr. Tro Kalayjian
CEO & Trading Analyst - Tony Pelz
Research Analyst - Dr. Andrew Goodwin
Research Analyst - Dr. Juan Pedro Rodríguez Serrate
Technical Analyst - Joe Gantoss
Research Analyst - Dr. Steven Murphy
Ed Silverman is the founding editor of Pharmalot and a prize-winning journalist who has covered the pharmaceutical industry for the past 15 years for The Star-Ledger of New Jersey, The Pink Sheet and, currently, as an editor-at-large for Med Ad News and R&D Directions.
An insider’s view on tech M&A transactions and trends, Inorganic Growth covers the numbers as well as the story behind them. Brenon Daly is the primary writer, with insights from across 451 Research. Hundreds of more in-depth M&A analysis reports and data can be found in 451 Research's subscriber-only Market Insight Serivce. Our M&A numbers come from The 451 M&A KnowledgeBase — a proprietary database of all tech deals since Jan. 1, 2002, sorted into more than 650 industry categories. The KnowledgeBase includes proprietary data on deal values and/or trailing revenues for key private M&A transactions. To request more information about our M&A research services, please go to the following URL: http://www.the451group.com/apply/apply.php?apply_page_id=604
Visit The 451 Group: Inorganic Growth (http://blogs.the451group.com/techdeals/)
The Burrill Report is written for everyone who wants to understand how biotechnology operates as a business. Each month the publication focuses on the health of the industry and the strategies that will be needed to be successful. It provides actionable market intelligence on the latest global developments and trends in the life sciences industry. Available monthly, subscribers also benefit from monthly and quarterly market financial and business statistics on:
- Public companies
- venture financings
- Project Runway – Follow the global life sciences companies filing for and completing their IPOs – and their post market performances
- Clinical Trials successes and failures
- M&A and Partnering deals
- Periodic country features on Canada, Europe and emerging countries such as China & India.
In addition, BR provides in-depth coverage on specific sectors of life sciences including: Personalized Medicine; Diagnostics, Medical Devices and Biogreentech (Ag-Bio and Biofuels/Bioenergy). Through weekly Burrill Indices, the progress and prospects of biotech companies by size, from small through to blue-chip are also tracked.
Visit: The Burrill Report to obtain your sample issue (http://www.burrillreport.com/)